ABSTRACT
Plant DNA barcoding has proven to be a handy tool for identifying botanical species. However, extracting DNA from woody materials is often a challenging task. Forensic applications, therefore, must be able to overcome the technical difficulties of this nature. A simple and successful adaptation, through a widely used method in forensic laboratories, using chemistry based on magnetic DNA isolation technology and a robotic platform, is presented here. The model case was the application of this adapted DNA extraction method for the identification of Aspidosperma spp., a genus comprising several species in all biomes of Brazil, including Cerrado and Rain Forest. Such technology adaptation can aid in the identification of seized material and help in investigations involving illegal logging and deforestation, ultimately contributing to environmental protection.
Subject(s)
Aspidosperma/genetics , DNA, Plant/isolation & purification , Wood/genetics , Brazil , Conservation of Natural Resources , Databases, Nucleic Acid , Forensic Genetics/methods , Humans , Pilot Projects , Polymerase Chain Reaction , Sequence Analysis, DNA , Species Specificity , Specimen Handling/methodsABSTRACT
Abstract Hidradenitis suppurativa is a chronic inflammatory skin disease, which affects 1% of the population, being more common in young, obese and smokers, and mainly affects armpits and groin, with formation of pustules, nodules, abscesses, scars and fistulas. Recently, its association with other autoimmune diseases such as psoriasis, psoriatic arthritis, pyoderma gangrenosum, pyogenic arthritis and ulcerative colitis have been reported. These associated forms are usually resistant to standard treatment, with immunobiologicals as promising therapy. The case of a rare form of association is reported, with only one case previously described in the literature: psoriasis arthritis, pyoderma gangrenosum, acne and hidradenitis suppurativa.
Subject(s)
Humans , Female , Young Adult , Arthritis, Psoriatic/pathology , Pyoderma Gangrenosum/pathology , Hidradenitis Suppurativa/pathology , Acne Vulgaris/pathology , Autoimmune Diseases/pathology , SyndromeABSTRACT
Hidradenitis suppurativa is a chronic inflammatory skin disease, which affects 1% of the population, being more common in young, obese and smokers, and mainly affects armpits and groin, with formation of pustules, nodules, abscesses, scars and fistulas. Recently, its association with other autoimmune diseases such as psoriasis, psoriatic arthritis, pyoderma gangrenosum, pyogenic arthritis and ulcerative colitis have been reported. These associated forms are usually resistant to standard treatment, with immunobiologicals as promising therapy. The case of a rare form of association is reported, with only one case previously described in the literature: psoriasis arthritis, pyoderma gangrenosum, acne and hidradenitis suppurativa.
Subject(s)
Acne Vulgaris/pathology , Arthritis, Psoriatic/pathology , Hidradenitis Suppurativa/pathology , Pyoderma Gangrenosum/pathology , Autoimmune Diseases/pathology , Female , Humans , Syndrome , Young AdultABSTRACT
Chikungunya fever has become a relevant public health problem in countries where epidemics occur. Until 2013, only imported cases occurred in the Americas, but in October of that year, the first cases were reported in Saint Marin island in the Caribbean. The first autochthonous cases were confirmed in Brazil in September 2014; until epidemiological week 37 of 2016, 236,287 probable cases of infection with Chikungunya virus had been registered, 116,523 of which had serological confirmation. Environmental changes caused by humans, disorderly urban growth and an ever-increasing number of international travelers were described as the factors responsible for the emergence of large-scale epidemics. Clinically characterized by fever and joint pain in the acute stage, approximately half of patients progress to the chronic stage (beyond 3 months), which is accompanied by persistent and disabling pain. The aim of the present study was to formulate recommendations for the diagnosis and treatment of Chikungunya fever in Brazil. A literature review was performed in the MEDLINE, SciELO and PubMed databases to ground the decisions for recommendations. The degree of concordance among experts was established through the Delphi method, involving 2 in-person meetings and several online voting rounds. In total, 25 recommendations were formulated and divided into 3 thematic groups: (1) clinical, laboratory and imaging diagnosis; (2) special situations; and (3) treatment. The first 2 themes are presented in part 1, and treatment is presented in part 2.
Subject(s)
Chikungunya Fever/diagnosis , Brazil , Chikungunya Fever/physiopathology , Chikungunya Fever/therapy , Consensus , Delphi Technique , Female , Humans , Male , Pregnancy , Pregnancy Complications, Infectious/diagnosis , Pregnancy Complications, Infectious/therapy , Rheumatology , Societies, MedicalABSTRACT
Chikungunya fever has become an important public health problem in countries where epidemics occur because half of the cases progress to chronic, persistent and debilitating arthritis. Literature data on specific therapies at the various phases of arthropathy caused by chikungunya virus (CHIKV) infection are limited, lacking quality randomized trials assessing the efficacies of different therapies. There are a few studies on the treatment of musculoskeletal manifestations of chikungunya fever, but these studies have important methodological limitations. The data currently available preclude conclusions favorable or contrary to specific therapies, or an adequate comparison between the different drugs used. The objective of this study was to develop recommendations for the treatment of chikungunya fever in Brazil. A literature review was performed via evidence-based selection of articles in the databases Medline, SciELO, PubMed and Embase and conference proceedings abstracts, in addition to expert opinions to support decision-making in defining recommendations. The Delphi method was used to define the degrees of agreement in 2 face-to-face meetings and several online voting rounds. This study is part 2 of the Recommendations of the Brazilian Society of Rheumatology (Sociedade Brasileira de Reumatologia - SBR) for the Diagnosis and Treatment of chikungunya fever and specifically addresses treatment.
Subject(s)
Chikungunya Fever/drug therapy , Brazil , Chikungunya Fever/diagnosis , Chikungunya Fever/rehabilitation , Consensus , Delphi Technique , Disease Progression , Humans , Physical Therapy Modalities , Rheumatology , Societies, MedicalABSTRACT
Abstract Chikungunya fever has become a relevant public health problem in countries where epidemics occur. Until 2013, only imported cases occurred in the Americas, but in October of that year, the first cases were reported in Saint Marin island in the Caribbean. The first autochthonous cases were confirmed in Brazil in September 2014; until epidemiological week 37 of 2016, 236,287 probable cases of infection with Chikungunya virus had been registered, 116,523 of which had serological confirmation. Environmental changes caused by humans, disorderly urban growth and an ever-increasing number of international travelers were described as the factors responsible for the emergence of large-scale epidemics. Clinically characterized by fever and joint pain in the acute stage, approximately half of patients progress to the chronic stage (beyond 3 months), which is accompanied by persistent and disabling pain. The aim of the present study was to formulate recommendations for the diagnosis and treatment of Chikungunya fever in Brazil. A literature review was performed in the MEDLINE, SciELO and PubMed databases to ground the decisions for recommendations. The degree of concordance among experts was established through the Delphi method, involving 2 in-person meetings and several online voting rounds. In total, 25 recommendations were formulated and divided into 3 thematic groups: (1) clinical, laboratory and imaging diagnosis; (2) special situations; and (3) treatment. The first 2 themes are presented in part 1, and treatment is presented in part 2.
Resumo A febre chikungunya tem se tornado um importante problema de saúde pública nos países onde ocorrem as epidemias. Até 2013, as Américas haviam registrado apenas casos importados quando, em outubro desse mesmo ano, foram notificados os primeiros casos na Ilha de Saint Martin, no Caribe. No Brasil, os primeiros relatos autóctones foram confirmados em setembro de 2014 e até a semana epidemiológica 37 de 2016 já haviam sido registrados 236.287 casos prováveis de infecção pelo chikungunya vírus (CHIKV), 116.523 confirmados sorologicamente. As mudanças ambientais causadas pelo homem, o crescimento urbano desordenado e o número cada vez maior de viagens internacionais têm sido apontados como os fatores responsáveis pela reemergência de epidemias em grande escala. Caracterizada clinicamente por febre e dor articular na fase aguda, em cerca de metade dos casos existe evolução para a fase crônica (além de três meses), com dor persistente e incapacitante. O objetivo deste trabalho foi elaborar recomendações para diagnóstico e tratamento da febre chikungunya no Brasil. Para isso, foi feita revisão da literatura nas bases de dados Medline, SciELO e PubMed, para dar apoio às decisões tomadas para definir as recomendações. Para a definição do grau de concordância foi feita uma metodologia Delphi, em duas reuniões presenciais e várias rodadas de votação on line. Foram geradas 25 recomendações, divididas em três grupos temáticos: (1) diagnóstico clínico, laboratorial e por imagem; (2) situações especiais e (3) tratamento. Na primeira parte estão os dois primeiros temas e o tratamento na segunda.
Subject(s)
Humans , Male , Female , Pregnancy , Chikungunya Fever/diagnosis , Pregnancy Complications, Infectious/diagnosis , Pregnancy Complications, Infectious/therapy , Rheumatology , Societies, Medical , Brazil , Delphi Technique , Consensus , Chikungunya Fever/physiopathology , Chikungunya Fever/therapyABSTRACT
Abstract Chikungunya fever has become an important public health problem in countries where epidemics occur because half of the cases progress to chronic, persistent and debilitating arthritis. Literature data on specific therapies at the various phases of arthropathy caused by chikungunya virus (CHIKV) infection are limited, lacking quality randomized trials assessing the efficacies of different therapies. There are a few studies on the treatment of musculoskeletal manifestations of chikungunya fever, but these studies have important methodological limitations. The data currently available preclude conclusions favorable or contrary to specific therapies, or an adequate comparison between the different drugs used. The objective of this study was to develop recommendations for the treatment of chikungunya fever in Brazil. A literature review was performed via evidence-based selection of articles in the databases Medline, SciELO, PubMed and Embase and conference proceedings abstracts, in addition to expert opinions to support decision-making in defining recommendations. The Delphi method was used to define the degrees of agreement in 2 face-to-face meetings and several online voting rounds. This study is part 2 of the Recommendations of the Brazilian Society of Rheumatology (Sociedade Brasileira de Reumatologia - SBR) for the Diagnosis and Treatment of chikungunya fever and specifically addresses treatment.
Resumo A febre chikungunya tem se tornado um importante problema de saúde pública nos países onde ocorrem as epidemias, visto que metade dos casos evolui com artrite crônica, persistente e incapacitante. Os dados na literatura sobre terapêuticas específicas nas diversas fases da artropatia ocasionada pela infecção pelo vírus chikungunya (CHIKV) são limitados, não existem estudos randomizados de qualidade que avaliem a eficácia das diferentes terapias. Há algumas poucas publicações sobre o tratamento das manifestações musculoesqueléticas da febre chikungunya, porém com importantes limitações metodológicas. Os dados atualmente disponíveis não permitem conclusões favoráveis ou contrárias a terapêuticas específicas, bem como uma adequada avaliação quanto à superioridade entre as diferentes medicações empregadas. O objetivo deste trabalho foi elaborar recomendações para o tratamento da febre chikungunya no Brasil. Foi feita uma revisão da literatura com seleção de artigos baseados em evidência, nas bases de dados Medline, SciELO, PubMed e Embase e de resumos de anais de congressos, além da opinião dos especialistas para dar apoio às decisões tomadas para definir as recomendações. Para a definição do grau de concordância foi feita uma metodologia Delphi, em duas reuniões presenciais e várias rodadas de votação on line. Este artigo refere-se à parte 2 das Recomendações da Sociedade Brasileira de Reumatologia para Diagnóstico e Tratamento da Febre Chikungunya, que trata especificamente do tratamento.
Subject(s)
Humans , Chikungunya Fever/drug therapy , Rheumatology , Societies, Medical , Brazil , Delphi Technique , Physical Therapy Modalities , Disease Progression , Consensus , Chikungunya Fever/diagnosis , Chikungunya Fever/rehabilitationABSTRACT
O tecido peri-implantar constitui uma adaptação da mucosa mastigatória aos diferentes sistemas de implante instalados na cavidade bucal. A falta do cemento radicular para ancoragem das fibras gengivais à superfície do implante resulta em uma orientação paralela das fibras ao seu redor. A ausência de uma inserção conjuntiva entre a mucosa e o implante pode sugerir uma deficiência da defesa estrutural na região e relacionar-se à progressão mais rápida das peri-implantites, quando comparadas às periodontites. Dessa forma, estudos abordam a importância da conexão epitelial para formação de um selamento adequado ao redor dos implantes. Outras discussões concentram-se em avaliar se uma situação de saúde gengival peri-implantar poderia estar correlacionada com a presença de uma quantidade específica (altura e espessura) da mucosa ceratinizada. Nesse contexto, a realização desse estudo teve como objetivo relacionar a importância estrutural do tecido mole e a influência do fenótipo gengival na manutenção da saúde peri-implantar. Os estudos revisados demonstram a importância de um bom selamento biológico em torno desse sistema, a função protetora que as estruturas desse tecido oferecem à interface osso-implante, e a discussão sobre a necessidade da presença de uma faixa de mucosa ceratinizada ao redor dos implantes dentários para um melhor prognóstico. Atualmente, as pesquisas apontam para a necessidade de mais estudos que avaliem a influência das características clínicas dos tecidos moles peri-implantares no estabelecimento e manutenção da saúde peri-implantar.
Peri-implant tissue is an adaptation of the masticatory mucosa to the different implant systems placed in the oral cavity. The lack of root cement to anchor gingival fibers to the surface of the implant is responsible for the parallel direction of the fibers around it. The absence of connective attachment between the mucosa and the implant may suggest a deficiency of the structural defenses in the region and may be associated with the more rapid progression of peri-implantitis than of periodontitis. Several studies have evaluated the importance of epithelial connections to form an adequate seal around implants. Other discussions have focused on the evaluation of whether peri-implant gingival health may be correlated with the presence of a specific amount (height and thickness) of keratinized mucosa. Thisstudy evaluated the association of the structural role of the soft tissue and the effect of gingiva phenotype on periimplant health. The studies that were reviewed stressed the importance of a good biological seal around the implant system, the protective function that the structures of this tissue provide to the bone-implant interface, and the discussion about the need to have a band of keratinized mucosa around tooth implants to ensure a better prognosis. Current studies point to the need to conduct further investigations to evaluate the effect of the clinical characteristics of soft peri-implant tissues so that peri-implant health may be ensured and preserved.
Subject(s)
Gingiva/anatomy & histology , Oral Health , Stomatitis , Dental Plaque , Dental Implantation/adverse effects , Mouth MucosaABSTRACT
BACKGROUND: Thalidomide is an anti-inflammatory and anti-angiogenic drug currently used for the treatment of several diseases, including erythema nodosum leprosum, which occurs in patients with lepromatous leprosy. In this research, we use DNA microarray analysis to identify the impact of thalidomide on gene expression responses in human cells after lipopolysaccharide (LPS) stimulation. We employed a two-stage framework. Initially, we identified 1584 altered genes in response to LPS. Modulation of this set of genes was then analyzed in the LPS stimulated cells treated with thalidomide. RESULTS: We identified 64 genes with altered expression induced by thalidomide using the rank product method. In addition, the lists of up-regulated and down-regulated genes were investigated by means of bioinformatics functional analysis, which allowed for the identification of biological processes affected by thalidomide. Confirmatory analysis was done in five of the identified genes using real time PCR. CONCLUSIONS: The results showed some genes that can further our understanding of the biological mechanisms in the action of thalidomide. Of the five genes evaluated with real time PCR, three were down regulated and two were up regulated confirming the initial results of the microarray analysis.
Subject(s)
Anti-Inflammatory Agents/pharmacology , Computational Biology , Gene Expression Profiling/methods , Inflammation/drug therapy , Leukocytes, Mononuclear/drug effects , Lipopolysaccharides/pharmacology , Oligonucleotide Array Sequence Analysis , Thalidomide/pharmacology , Cells, Cultured , Gene Expression Regulation/drug effects , Humans , Inflammation/genetics , Inflammation/immunology , Leukocytes, Mononuclear/immunology , Leukocytes, Mononuclear/metabolism , RNA, Messenger/metabolism , Real-Time Polymerase Chain ReactionABSTRACT
Este trabalho tem por objetivo apresentar concepções de sofrimento e terapêuticas dos usuários de um ambulatório de Saúde Mental de um posto de saúde localizado na zonanorte do Rio de Janeiro. Estas concepções, calcadas num universo holista e hierárquico de valor, contrastam com as concepções de sofrimento, pessoa e terapêuticas próprias das práticas psi, indissociáveis da perspectiva individualista que lhe deu origem, cuja concepção de pessoa é calcada na experiência de uma interioridade psicológica, dotada de liberdade deescolha, autonomia, apontando, conseqüentemente, para concepções acerca do adoecimento e da terapêutica bastante diferentes daquelas próprias a uma configuração hierárquica de valores. Nesse sentido, discutem-se as repercussões que essas diferenças trazem para o estabelecimento de uma relação terapêutica. Observou-se que as concepções de sofrimento e a terapêutica dos entrevistados situam-se na configuração do nervoso, na qual aspectos físicos e morais da perturbação estão imbricados de forma indissociável. Na medida em que eles se auto-representam a partir de suas relações familiares e laborativas, a construção do que seja perturbação está referida a essa relacionalidade, que lhes confere uma identidade numa organização hierárquica. A psicoterapia é também englobada por essa mesma lógica, sendo deslocada do seu sentidoindividualista original, para ser ressignificada à luz do modelo físico-moral da perturbação eda relacionalidade própria à configuração do nervoso. Dessa forma, entende-se a psicoterapia como conversa que visa o desabafo, botar para fora os problemas, assim como forma de pensar em outras coisas que não o problema, duas estratégias consideradas terapêuticas na configuração do nervoso.
This work aims to introduce the conceptions of suffering and therapeutics in patients of a public Mental Health clinic. These, inserted in a holistic and hierarchic universe of value,contrast to the conceptions of suffering, person and therapeutics of psychological practices, which are based on individualistic values, on the experiences of a psychological inner self, freedom of choice and self-government. Thus, the consequences of this difference to thetherapeutic relation are discussed.The study perceives that the interviewees` conceptions fits in the nervous configuration, in which physical and moral aspects of perturbation are imbricate. The sense ofperturbation involves a process of self-representation emerged from interviewees familial and laborious relationships, that confer an identity in a hierarchical organization on them. Thepsychotherapy is also encompassed by the nervous configuration, differing from its original individualistic signification. In this sense, psychotherapy is treated as a conversation that has in view to spit it out as well as a way of thinking about other things two strategiesconsidered therapeutical in the nervous configuration.
Subject(s)
Humans , Male , Female , Delivery of Health Care/ethics , Mental Health , Psychology, Clinical/methods , Mental Health Services , Mental Health Services/trends , Medical Care/ethics , Medical Care/methods , Ambulatory Care Facilities/trends , Psychotherapy/ethicsABSTRACT
We studied clinical and laboratorial features of 73 patients with endogenous Cushing's syndrome, subdivided as follows: 46 (63%) with Cushing's disease (CD), 21 (28.7%) with an adrenal tumor and 6 (8.2%) with ectopic ACTH secretion (EAS). The rate of typical manifestations of hypercortisolism was similar regardless its etiology. In 100% of cases of Cushing's syndrome we observed serum cortisol levels greater than 1.8 microg/dL in low-dose dexamethasone (DMS) suppression tests, as well as elevation of serum or salivary midnight cortisol. However, urinary free cortisol was normal in 11.5% of patients. ACTH levels were suppressed in patients with adrenal tumors, normal or high in CD and always high in EAS. In the 8-mg overnight DMS suppression test, serum cortisol suppression > 50% was observed in 78.2% of cases of CD and in 33.3% of subjects with EAS, while an 80% suppression was only seen in CD. After stimulation with CRH or DDAVP an ACTH increase > 35% occurred in 81% of individuals with CD and 16.6% of those with EAS, while an ACTH increase > 50 achieved 100% specificity. Moreover, the combination of serum cortisol suppression > 50% and an ACTH increase > 35% in both tests only occurred in Cushing's disease. Pituitary magnetic resonance imaging identified 100% of macroadenomas and 59.4% of microadenomas in patients with CD. Among 10 patients that underwent bilateral inferior petrosal sinus sampling, a central-to-peripheral ACTH gradient > 3 after CRH or DDAVP had 90% sensitivity and 100% specificity for Cushing's disease.
Subject(s)
ACTH Syndrome, Ectopic/diagnosis , Cushing Syndrome/diagnosis , Dexamethasone , Glucocorticoids , Hydrocortisone/blood , ACTH Syndrome, Ectopic/etiology , Adenoma/diagnosis , Adolescent , Adrenal Gland Neoplasms/diagnosis , Adult , Child , Child, Preschool , Cushing Syndrome/etiology , Cushing Syndrome/physiopathology , Dexamethasone/administration & dosage , Diagnosis, Differential , Epidemiologic Methods , Female , Glucocorticoids/administration & dosage , Humans , Hydrocortisone/urine , Magnetic Resonance Imaging , Male , Middle Aged , Sensitivity and Specificity , Sex FactorsABSTRACT
Avaliamos as características clínico-laboratoriais de 73 pacientes com síndrome de Cushing (SC) endógena, assim distribuídos: 46 (63 por cento) com doença de Cushing (DC), 21 (28,7 por cento) com tumores adrenais (TA) e 6 (8,2 por cento) com a síndrome do ACTH ectópico (SAE). A freqüência de manifestações clássicas do hipercortisolismo foi similar, independentemente da etiologia da SC. Em 100 por cento dos casos de SC, observaram-se níveis do cortisol sérico (CS) > 1,8 µg/dL após supressão com doses baixas de dexametasona (DMS), além de elevação do cortisol à meia-noite (sérico ou salivar). Contudo, o cortisol livre urinário foi normal em 11,5 por cento dos pacientes. Os níveis de ACTH mostraram-se suprimidos nos pacientes com TA, normais ou elevados na DC e sempre elevados na SAE. No teste de supressão noturna com 8 mg de DMS, supressão do CS > 50 por cento foi observada em 78,2 por cento dos casos de DC e 33,3 por cento dos casos de SAE, enquanto uma supressão > 80 por cento foi exclusiva da DC. Após estímulo com CRH ou DDAVP, um incremento do ACTH > 35 por cento aconteceu em 81 por cento dos indivíduos com DC e em 16,6 por cento daqueles com SAE, ao passo que um incremento do ACTH > 50 por cento restringiu-se à DC. A combinação de incremento do ACTH > 35 e supressão do CS > 50 por cento foi também exclusiva da DC. A ressonância magnética visualizou 100 por cento dos macroadenomas e 59,4 por cento dos microadenomas hipofisários nos casos de DC. Em 10 pacientes submetidos ao cateterismo bilateral do seio petroso inferior, um gradiente centro-periferia de ACTH > 3 pós-CRH ou DDAVP teve sensibilidade de 90 por cento e especificidade de 100 por cento para a doença de Cushing.
We studied clinical and laboratorial features of 73 patients with endogenous Cushings syndrome, subdivided as follows: 46 (63 percent) with Cushings disease (CD), 21 (28.7 percent) with an adrenal tumor and 6 (8.2 percent) with ectopic ACTH secretion (EAS). The rate of typical manifestations of hypercortisolism was similar regardless its etiology. In 100 percent of cases of Cushings syndrome we observed serum cortisol levels greater than 1.8 µg/dL in low-dose dexamethasone (DMS) suppression tests, as well as elevation of serum or salivary midnight cortisol. However, urinary free cortisol was normal in 11.5 percent of patients. ACTH levels were suppressed in patients with adrenal tumors, normal or high in CD and always high in EAS. In the 8-mg overnight DMS suppression test, serum cortisol suppression > 50 percent was observed in 78.2 percent of cases of CD and in 33.3 percent of subjects with EAS, while an 80 percent suppression was only seen in CD. After stimulation with CRH or DDAVP an ACTH increase > 35 percent occurred in 81 percent of individuals with CD and 16.6 percent of those with EAS, while an ACTH increase > 50 achieved 100 percent specificity. Moreover, the combination of serum cortisol suppression > 50 percent and an ACTH increase > 35 percent in both tests only occurred in Cushings disease. Pituitary magnetic resonance imaging identified 100 percent of macroadenomas and 59.4 percent of microadenomas in patients with CD. Among 10 patients that underwent bilateral inferior petrosal sinus sampling, a central-to-peripheral ACTH gradient > 3 after CRH or DDAVP had 90 percent sensitivity and 100 percent specificity for Cushings disease.
Subject(s)
Adolescent , Adult , Child , Child, Preschool , Female , Humans , Male , Middle Aged , ACTH Syndrome, Ectopic/diagnosis , Cushing Syndrome/diagnosis , Dexamethasone , Glucocorticoids , Hydrocortisone/blood , ACTH Syndrome, Ectopic/etiology , Adenoma/diagnosis , Adrenal Gland Neoplasms/diagnosis , Cushing Syndrome/etiology , Cushing Syndrome/physiopathology , Diagnosis, Differential , Dexamethasone/administration & dosage , Epidemiologic Methods , Glucocorticoids/administration & dosage , Hydrocortisone/urine , Magnetic Resonance Imaging , Sensitivity and Specificity , Sex FactorsABSTRACT
Macroprolactinemia is characterized by the predominance in the serum of macroprolactin, a prolactin (PRL) with high molecular mass and low biological activity that does not need treatment. The prevalence of macroprolactinemia was evaluated in 115 consecutive patients with hyperprolactinemia. Among them, 19 (16.5%) had solely macroprolactinemia, 4 (3.5%) polycystic ovary syndrome, 7 (6.1%) acromegaly, 8 (6.9%) idiopathic hyperprolactinemia, 10 (8.6%) primary hypothyroidism, 14 (12.2%) clinically non-functioning pituitary adenomas, 20 (17.4%) drug-induced hyperprolactinemia and 33 (28.7%) prolactinomas. The diagnosis of macroprolactinemia was established by the demonstration of a PRL recovery < 30% after treatment of sera with polyethylene glycol. Among the 19 patients with isolated macroprolactinemia, 16 (84.2%) were female and 12 (63.2%) were asymptomatic, while 4 (21%) presented with oligomenorrhea and 3 (15.8%) with galactorrhea. In contrast, only 11.5% of individuals with other causes of hyperprolactinemia were asymptomatic (p< 0.001). Prolactin levels in cases of macroprolactin ranged from 45.1 to 404 ng/mL (mean 113.3 +/- 94.5) but in 15 (78.9%) were < 100 ng/mL. Our findings demonstrate that macroprolactinemia is a common condition and, therefore, we suggest that it should be routinely screened in patients with hyperprolactinemia.
Subject(s)
Hyperprolactinemia/epidemiology , Prolactin/blood , Adult , Analysis of Variance , Biomarkers/blood , Brazil/epidemiology , Chemical Precipitation , Comorbidity , Female , Humans , Hyperprolactinemia/etiology , Luminescent Measurements , Male , Middle Aged , Polyethylene Glycols , PrevalenceABSTRACT
Macroprolactinemia caracteriza-se pelo predomínio no soro de uma prolactina (PRL) de alto peso molecular e baixa atividade biológica que não requer tratamento. A prevalência de macroprolactinemia foi avaliada em 115 pacientes consecutivos com hiperprolactinemia. Entre eles, 19 (16,5 por cento) tinham exclusivamente macroprolactinemia, 4 (3,5 por cento) síndrome dos ovários policísticos, 7 (6,1 por cento) acromegalia, 8 (6,9 por cento) hiperprolactinemia idiopática, 10 (8,7 por cento) hipotiroidismo primário, 14 (12,2 por cento) adenomas clinicamente não-funcionantes, 20 (17,4 por cento) hiperprolactinemia farmacológica e 33 (28,7 por cento) prolactinomas. O diagnóstico de macroprolactinemia foi estabelecido pela obtenção de uma recuperação da PRL < 30 por cento após tratamento do soro com polietilenoglicol. Dentre os 19 pacientes com macroprolactinemia isolada, 16 (84,2 por cento) eram mulheres e 12 (63,2 por cento) eram assintomáticos, enquanto 4 (21 por cento) tinham oligomenorréia e 3 (15,8 por cento), galactorréia. Em contraste, apenas 11,5 por cento dos indivíduos com outras causas de hiperprolactinemia eram assintomáticos (p< 0,001). Os níveis de PRL nos casos de macroprolactinemia variaram de 45,1 a 404 ng/mL (média de 113,3 ± 94,5), mas em 15 (78,9 por cento) foram < 100 ng/mL. Nossos achados demonstram que macroprolactinemia é uma condição freqüente e, assim, sugerimos que seja rotineiramente pesquisada em pacientes com hiperprolactinemia.
Macroprolactinemia is characterized by the predominance in the serum of macroprolactin, a prolactin (PRL) with high molecular mass and low biological activity that does not need treatment. The prevalence of macroprolactinemia was evaluated in 115 consecutive patients with hyperprolactinemia. Among them, 19 (16.5 percent) had solely macroprolactinemia, 4 (3.5 percent) polycystic ovary syndrome, 7 (6.1 percent) acromegaly, 8 (6.9 percent) idiopathic hyperprolactinemia, 10 (8.6 percent) primary hypothyroidism, 14 (12.2 percent) clinically non-functioning pituitary adenomas, 20 (17.4 percent) drug-induced hyperprolactinemia and 33 (28.7 percent) prolactinomas. The diagnosis of macroprolactinemia was established by the demonstration of a PRL recovery < 30 percent after treatment of sera with polyethylene glycol. Among the 19 patients with isolated macroprolactinemia, 16 (84.2 percent) were female and 12 (63.2 percent) were asymptomatic, while 4 (21 percent) presented with oligomenorrhea and 3 (15.8 percent) with galactorrhea. In contrast, only 11.5 percent of individuals with other causes of hyperprolactinemia were asymptomatic (p< 0.001). Prolactin levels in cases of macroprolactin ranged from 45.1 to 404 ng/mL (mean 113.3 ± 94.5) but in 15 (78.9 percent) were < 100 ng/mL. Our findings demonstrate that macroprolactinemia is a common condition and, therefore, we suggest that it should be routinely screened in patients with hyperprolactinemia.
